Articles related to MULTIPLE SCLEROSIS (MS)

Early use of high-efficacy disease-modifying therapies in pediatric-onset MS patients with minimal disability reduces the risk of progression by 59% compared to no treatment.

A recent study involving 230 untreated relapsing-remitting MS patients found that vitamin D levels below 20 ng/mL were associated with a more than twofold increase in the risk of disease activity. This finding emphasizes the potential importance of vitamin D monitoring and management in MS patient care.

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

This study of more than 1,100 MS patients reveals a significant perception of higher empathy in AI-generated responses compared to those from neurologists, underlining the potential to tailor AI communication tools to improve patient interactions.

Ensuring patient comfort during MRI scans is not just about improving the experience but also about enhancing diagnostic accuracy. Insights on optimal patient preparation, from clothing choices to personalizing auditory experiences, can lead to more effective and efficient MRI procedures.

In the evolving landscape of MS treatment, the strategic choice between early aggressive and escalation therapies is critical. Understanding the nuances of patient-specific factors, such as age and disease activity, can significantly influence outcomes and guide effective management.